Patrick Lamy sold $340K of Akero Therapeutics (AKRO)

Executed May 7 2025, disclosed May 9 2025, 2 days later.

Value, as filed

$340K

8,000 sh across 2 lots

Executed

May 7 2025

the trade date, as filed

Disclosed

May 9 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

PL Patrick Lamy Senior VP, Commercial Strategy profile →

Patrick Lamy (Senior VP, Commercial Strategy) filed 5 Form 4 reports in the past 24 months (0 purchases, 5 sales), most often in AKRO. The largest single filing was $340K of AKRO (8,000 sh across 2 lots, as filed), executed May 7 2025.

The name

AKRO AKRO AKRO · 63 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Patrick Lamy in AKRO

AKROSALE Akero Therapeutics, Inc. $106K
2,000 sh × $52.88
Exec Jul 1 2025
Filed Jul 3 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $167K
3,300 sh × $50.46
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $200K
4,000 sh × $50.00
Exec May 22 2025
Filed May 23 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $285K
5,000 sh × $57.03
Exec Jan 27 2025
Filed Jan 29 2025 · 5:30 PM ET